VenoVision

Non-invasive, easy-to-use advanced cardiac and hemodynamic monitoring.

Health Tech & Life Sciences
Active
Pre-Seed Jerusalem, Israel Founded 2022
Last updated 2026-06-18
Total raised
$188K
Last: Grant 2023-11
Stage
Pre-Seed
Founded
2022
Headcount
1
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

VenoVision provides the missing non-invasive advanced cardiac monitoring needed to improve the lives of millions of heart failure and at-risk patients.

VenoVision brings the power of ICU cardiac monitoring to lower resource settings, giving medical teams the hemodynamic data needed to adjust therapy in time to reduce ICU admissions and hospitalizations. VenoVision is a low cost, easy-to-use, thermal imaging-based hemodynamic monitoring device and platform for the entire continuum of care - inpatient, outpatient and home settings. It uniquely overcomes the challenges of monitoring obese patients.

The company is focused on driving down the billions of dollars currently spent on preventable deterioration and rehospitalizations. It has completed a proof-of-concept clinical trial, designed a prototype, and patented its technology. VenoVision was conceptualized in the Hebrew University of Jerusalem's BioDesign program, was a MassChallenge Israel 2021 Finalist, and is a Health Wildcatters Dallas accelerator (Dallas, USA) 2022 portfolio company. VenoVision won "most innovative" award at M2D2 Impact 2023.

Funding history · 5 rounds · $188K total

2023-11
Grant $8K
2023-11
$50K
2023-04
$50K
2023-01
$30K
2016-01
Grant Undisclosed

Q&A

What is VenoVision's primary focus?
VenoVision focuses on providing non-invasive, easy-to-use advanced cardiac and hemodynamic monitoring to improve the lives of heart failure and at-risk patients.
When was VenoVision founded?
VenoVision was founded in September 2022.
What is VenoVision's current employee count?
VenoVision has 1-10 employees.
What is VenoVision's total funding to date?
VenoVision has raised a total of $187,500 USD across multiple funding rounds.
What was VenoVision's most recent funding round?
VenoVision received a Grant in November 2023 for $7,500 USD.
Has VenoVision patented its technology?
Yes, VenoVision has patented its technology and holds one patent.
What recognition did VenoVision receive in 2023?
VenoVision won the "most innovative" award at M2D2 Impact 2023.
Where is VenoVision headquartered?
VenoVision is headquartered in Jerusalem, Israel.

Team · 4

Founder · Co-founder
LinkedIn ↗
Founder · Co-founder
Founder · Co-founder
Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesMedical Monitors
Technologies
SensingBiometricsInfraredArtificial IntelligenceComputer VisionMachine LearningImage Recognition
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical EquipmentHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

obesityhospitalsmedical-technologiesearly-detectiondoctorshome-caremedical-devicescritical-carecardiovascularartificial-intelligenceremote-monitoringdigital-healthcareheart-failurecardiologythermal-imagingmonitoringnon-invasivealert-systemdecision-supporthealthcare-providers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitevenovision.com/
LinkedInlinkedin.com/company/85630381

Identifiers & details

Founded2022-9
Employees (exact)1
OfficesUnited States

Radar intelligence

Web history (Wayback)

Domainvenovision.com

Certificate / subdomain footprint

Subdomains2